AccScience Publishing / BH / Volume 2 / Issue 1 / DOI: 10.36922/bh.1978
Submit to BH
Cite this article
37
Download
470
Views
Journal Browser
Volume | Year
Issue
Search
Forthcoming Issue
Current Issue
View All
News and Announcements
View All
ORIGINAL RESEARCH ARTICLE

Efficacy and cognitive impact of modified Atkins diet in adults with drug-resistant epilepsy

Huixin Liu1,2 ,  Hongjuan Lu1 ,  Yichen Ji1 ,  Wenjian Liu1 ,  Haoran Yang1 ,  Xuan Zhang1 ,  Jiayi Li1 ,  Wei Sun1*
Show Less
1 Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China
2 Department of Neurology, Emergency General Hospital, Beijing, China
Brain & Heart 2024, 2(1), 1978 https://doi.org/10.36922/bh.1978
Submitted: 7 October 2023 | Accepted: 5 January 2024 | Published: 16 February 2024
© 2024 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Download PDF
Cite
XML
Abstract

This study aims to explore the efficacy and cognitive impact of the modified Atkins diet (MAD) in adults with drug-resistant epilepsy, as well as to analyze changes in epileptiform activity during ketogenic diet (KD) intervention. We performed a prospective, open-label study with patients aged 16 – 60 years who met the International League Against Epilepsy (ILAE) criteria for drug-resistant epilepsy. Sixteen patients were enrolled in this study, and baseline clinical and electroencephalography (EEG) characteristics, along with neuropsychological tests, were collected before and after 3 months of KD. Patients were divided into responders (≥50% seizure reduction) and non-responders (<50% seizure reduction) according to the clinical efficacy of the KD. Results indicate that 37.5% of patients reported a ≥50% seizure reduction after 3 months. In terms of safety, 37.5% of patients reported adverse effects, including constipation, abdominal pain, and nausea. In addition, a statistically significant increase in the level of total cholesterol was observed (P = 0.037) after diet treatment. Regarding cognitive impact, there was a significant improvement in auditory verbal learning test (AVLT) instant recall scale scores (P = 0.017). In terms of EEG characteristics, MAD significantly reduces interictal epileptic discharge (IED) index in non-rapid eye movement 2 (NREM2) after 3 months. No clinical predictors or EEG characteristics of MAD efficacy were identified. In conclusion, MAD can be safely and effectively practiced by adults with drug-resistant epilepsy. KD treatment has a significant impact on AVLT instant recall and can reduce the IED index in NREM2.

Keywords
Modified Atkins diet
Drug-resistant epilepsy
Cognitive function
Electroencephalography
Funding
Beijing Hospitals Authority Clinical Medicine Development of special funding
References
  1. Thijs RD, Surges R, O’brien TJ, Sander JW. Epilepsy in adults. Lancet. 2019;393(10172):689-701. doi: 10.1016/S0140-6736(18)32596-0

 

  1. Ding D, Zhou D, Sander JW, Wang W, Li S, Hong Z. Epilepsy in China: Major progress in the past two decades. Lancet Neurol. 2021;20(4):316-326. doi: 10.1016/S1474-4422(21)00023-5

 

  1. Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE commission on therapeutic strategies. Epilepsia. 2010;51(6):1069-1077. doi: 10.1111/j.1528-1167.2009.02397.x

 

  1. Yoo JY, Panov F. Identification and treatment of drug-resistant epilepsy. Continuum (Minneap Minn). 2019;25(2):362-380. doi: 10.1212/con.0000000000000710

 

  1. Wheless JW. History of the ketogenic diet. Epilepsia. 2008;49(Suppl 8):3-5. doi: 10.1111/j.1528-1167.2008.01821.x

 

  1. Neal EG, Chaffe H, Schwartz RH, et al. The ketogenic diet for the treatment of childhood epilepsy: A randomised controlled trial. Lancet Neurol. 2008;7(6):500-506. doi: 10.1016/S1474-4422(08)70092-9

 

  1. Freeman JM, Vining EP, Kossoff EH, Pyzik PL, Ye X, Goodman SN. A blinded, crossover study of the efficacy of the ketogenic diet. Epilepsia. 2009;50(2):322-325. doi: 10.1111/j.1528-1167.2008.01740.x

 

  1. Dressler A, Stocklin B, Reithofer E, et al. Long-term outcome and tolerability of the ketogenic diet in drug-resistant childhood epilepsy--the Austrian experience. Seizure. 2010;19(7):404-408. doi: 10.1016/j.seizure.2010.06.006

 

  1. Green SF, Nguyen P, Kaalund-Hansen K, Rajakulendran S, Murphy E. Effectiveness, retention, and safety of modified ketogenic diet in adults with epilepsy at a tertiary-care centre in the UK. J Neurol. 2020;267(4):1171-1178. doi: 10.1007/s00415-019-09658-6

 

  1. Kverneland M, Molteberg E, Iversen PO, et al. Effect of modified Atkins diet in adults with drug-resistant focal epilepsy: A randomized clinical trial. Epilepsia. 2018;59(8):1567-1576. doi: 10.1111/epi.14457

 

  1. IJff DM, Postulart D, Lambrechts DA, et al. Cognitive and behavioral impact of the ketogenic diet in children and adolescents with refractory epilepsy: A randomized controlled trial. Epilepsy Behav. 2016;60:153-157. doi: 10.1016/j.yebeh.2016.04.033

 

  1. Zhu D, Wang M, Wang J, et al. Ketogenic diet effects on neurobehavioral development of children with intractable epilepsy: A prospective study. Epilepsy Behav. 2016;55:87-91. doi: 10.1016/j.yebeh.2015.12.011

 

  1. Van Berkel AA, IJff DM, Verkuyl JM. Cognitive benefits of the ketogenic diet in patients with epilepsy: A systematic overview. Epilepsy Behav. 2018;87:69-77. doi: 10.1016/j.yebeh.2018.06.004

 

  1. Kossoff EH, Dorward JL. The modified Atkins diet. Epilepsia. 2008;49(Suppl 8):37-41. doi: 10.1111/j.1528-1167.2008.01831.x

 

  1. Cervenka MC, Wood S, Bagary M, et al. International recommendations for the management of adults treated with ketogenic diet therapies. Neurol Clin Pract. 2021;11(5):385-397. doi: 10.1212/CPJ.0000000000001007

 

  1. Sun Y, Seneviratne U, Perucca P, et al. Generalized polyspike train: An EEG biomarker of drug-resistant idiopathic generalized epilepsy. Neurology. 2018;91(19):e1822-e1830. doi: 10.1212/WNL.0000000000006472

 

  1. Brenner RP, Atkinson R. Generalized paroxysmal fast activity: Electroencephalographic and clinical features. Ann Neurol. 1982;11(4):386-390. doi: 10.1002/ana.410110412

 

  1. Ye F, Li XJ, Jiang WL, Sun HB, Liu J. Efficacy of and patient compliance with a ketogenic diet in adults with intractable epilepsy: A meta-analysis. J Clin Neurol. 2015;11(1):26-31. doi: 10.3988/jcn.2015.11.1.26

 

  1. Mutarelli A, Nogueira A, Felix N, et al. Modified Atkins diet for drug-resistant epilepsy: A systematic review and meta-analysis of randomized controlled trials. Seizure Eur J Epilepsy. 2023;112:77-83. doi: 10.1016/j.seizure.2023.09.010

 

  1. Manral M, Dwivedi R, Gulati S, et al. Safety, efficacy, and tolerability of modified atkins diet in persons with drug-resistant epilepsy. Neurology. 2023;100(13):e1376-e1385. doi: 10.1212/wnl.0000000000206776

 

  1. Zare M, Okhovat AA, Esmaillzadeh A, et al. Modified Atkins diet in adult with refractory epilepsy: A controlled randomized clinical trial. Iran J Neurol. 2017;16(2):72-77.

 

  1. Liu H, Yang Y, Wang Y, et al. Ketogenic diet for treatment of intractable epilepsy in adults: A meta-analysis of observational studies. Epilepsia Open. 2018;3(1):9-17. doi: 10.1002/epi4.12098

 

  1. Lucchi C, Marchio M, Caramaschi E, et al. Electrographic changes accompanying recurrent seizures under ketogenic diet treatment. Pharmaceuticals (Basel). 2017;10(4):82. doi: 10.3390/ph10040082

 

  1. Kverneland M, Tauboll E, Selmer KK, Iversen PO, Nakken KO. Modified Atkins diet may reduce serum concentrations of antiepileptic drugs. Acta Neurol Scand. 2015;131(3):187-190. doi: 10.1111/ane.12330

 

  1. Kverneland M, Taubøll E, Molteberg E, et al. Pharmacokinetic interaction between modified Atkins diet and antiepileptic drugs in adults with drug-resistant epilepsy. Epilepsia. 2019;60(11):2235-2244. doi: 10.1111/epi.16364

 

  1. Klein P, Tyrlikova I, Mathews GC. Dietary treatment in adults with refractory epilepsy: A review. Neurology. 2014;83(21):1978-1985. doi: 10.1212/WNL.0000000000001004

 

  1. Cervenka MC, Henry BJ, Felton EA, Patton K, Kossoff EH. Establishing an adult epilepsy diet center: Experience, efficacy and challenges. Epilepsy Behav. 2016;58:61-68. doi: 10.1016/j.yebeh.2016.02.038

 

  1. Kossoff EH, Zupec-Kania BA, Auvin S, et al. Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group. Epilepsia Open. 2018;3(2):175-192. doi: 10.1002/epi4.12225

 

  1. Cervenka MC, Patton K, Eloyan A, Henry B, Kossoff EH. The impact of the modified Atkins diet on lipid profiles in adults with epilepsy. Nutr Neurosci. 2014;19(3):131-137. doi: 10.1179/1476830514y.0000000162

 

  1. De Souza Neves G, Dos Santos Lunardi M, Papini Gabiatti M, et al. Cardiometabolic risk and effectiveness of the modified Atkins Ketogenic Diet for adult patients with pharmacoresistant epilepsies in a middle-income country. Epilepsy Res. 2020;160:106280. doi: 10.1016/j.eplepsyres.2020.106280

 

  1. Neves GS, Lunardi MS, Lin K, Rieger DK, Ribeiro LC, Moreira JD. Ketogenic diet, seizure control, and cardiometabolic risk in adult patients with pharmacoresistant epilepsy: A review. Nutr Rev. 2021;79(8):931-944. doi: 10.1093/nutrit/nuaa112

 

  1. Shegelman A, Carson KA, Mcdonald TJ, Henry-Barron BJ, Diaz-Arias LA, Cervenka MC. The psychiatric effects of ketogenic diet therapy on adults with chronic epilepsy. Epilepsy Behav. 2021;117:107807. doi: 10.1016/j.yebeh.2021.107807

 

  1. Kessler SK, Gallagher PR, Shellhaas RA, Clancy RR, Bergqvist AG. Early EEG improvement after ketogenic diet initiation. Epilepsy Res. 2011;94(1-2):94-101. doi: 10.1016/j.eplepsyres.2011.01.012

 

  1. Li B, Tong L, Jia G, Sun R. Effects of ketogenic diet on the clinical and electroencephalographic features of children with drug therapy-resistant epilepsy. Exp Ther Med. 2013;5(2):611-615. doi: 10.3892/etm.2012.823

 

  1. Hallbook T, Kohler S, Rosen I, Lundgren J. Effects of ketogenic diet on epileptiform activity in children with therapy resistant epilepsy. Epilepsy Res. 2007;77(2-3):134-140. doi: 10.1016/j.eplepsyres.2007.09.008

 

  1. Ebus SC, Lambrechts DA, Herraets IJ, et al. Can an early 24-hour EEG predict the response to the ketogenic diet? A prospective study in 34 children and adults with refractory epilepsy treated with the ketogenic diet. Seizure. 2014;23(6):468-474. doi: 10.1016/j.seizure.2014.03.008

 

  1. Beniczky S, Jose Miranda M, Alving J, Povlsen JH, Wolf P. Effectiveness of the ketogenic diet in a broad range of seizure types and EEG features for severe childhood epilepsies. Acta Neurol Scand. 2010;121(1):58-62. doi: 10.1111/j.1600-0404.2009.01303.x

 

  1. Sagi V, Kim I, Bhatt AB, Di Bonaventura C. Generalized paroxysmal fast activity in EEG: An unrecognized finding in genetic generalized epilepsy. Epilepsy Behav. 2017;76:101-104. doi: 10.1016/j.yebeh.2017.08.019

 

  1. Cerulli Irelli E, Barone FA, Mari L, et al. Generalized fast discharges along the genetic generalized epilepsy spectrum: Clinical and prognostic significance. Front Neurol. 2022;13:844674. doi: 10.3389/fneur.2022.844674

 

  1. Jensen CD, Gesche J, Kroigard T, Beier CP. Prognostic value of generalized polyspike trains and prolonged epileptiform EEG runs. J Clin Neurophysiol. 2021;38(3):208-212. doi: 10.1097/WNP.0000000000000679
Conflict of interest
There are no conflicts of interest to declare.
Share
Back to top
Brain & Heart, Electronic ISSN: 2972-4139 Published by AccScience Publishing
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here
Accept